{"nct_id":"NCT03901339","title":"Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2019-05-08","start_date_type":"ACTUAL","primary_completion_date":"2023-10-20","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-20","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}